Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Emergency Radiology|March 1, 2017
The spectrum of traumatic injuries at the craniocervical junction: a review of imaging findings and managementJuveria Siddiqui, Patrick J Grover, Hegoda Levansri Makalanda, et al.
European Journal of Neurology|May 26, 2022
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosisAshok Adams, William Tilden, Jonathan Bestwick, et al.
Annals of Clinical and Translational Neurology|July 12, 2017
Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosisCesar Alvarez-Gonzalez, Ashok Adams, Joela Mathews, et al.
Journal of Neurology|March 5, 2018
No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalationStephen Keddie, Ashok Adams, Andrew R C Kelso, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|January 10, 2024
Enhancing paranasal sinus disease detection with AutoML: efficient AI development and evaluation via magnetic resonance imagingRyan Chin Taw Cheong, Susan Jawad, Ashok Adams, et al.
Endocrine Connections|April 10, 2019
Impact of thyroiditis on 131I uptake during ablative therapy for differentiated thyroid cancerEugenie S Lim, Shanty G Shah, Mona Waterhouse, et al.
Multiple Sclerosis and Related Disorders|December 25, 2025
The brainstem signature of multiple sclerosis: predictable lesions, consistent syndromesMohammad Wafa, Khalid Nuh, Gavin Giovannoni, et al.
Therapeutic Advances in Neurological Disorders|November 13, 2023
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosisKimberley Allen-Philbey, Stefania De Trane, Amy MacDougall, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2024
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cellsFrancesca Ammoscato, Mohammad Wafa, Justyna Skonieczna, et al.
Multiple Sclerosis and Related Disorders|November 13, 2018
Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policiesZhifeng Mao, César Álvarez-González, Kimberley Allen-Philbey, et al.
Pageof 4